Retinal Vein Occlusion:グローバル臨床試験レビューH1, 2013...市場調査レポートについてご紹介

【英文タイトル】Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Retinal Vein Occlusion 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Retinal Vein Occlusion 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Allergan, Inc. 33
Clinical Trial Overview of Allergan, Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Genentech, Inc. 35
Clinical Trial Overview of Genentech, Inc. 35
Novartis Pharmaceuticals Corporation 36
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 36
Regeneron Pharmaceuticals, Inc. 37
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 37
Mid Atlantic Retina 38
Clinical Trial Overview of Mid Atlantic Retina 38
Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
Clinical Trial Overview of Chengdu Kanghong Pharmaceuticals Group Co., Ltd. 39
Aleris Helse AS 40
Clinical Trial Overview of Aleris Helse AS 40
Opocrin S.p.A 41
Clinical Trial Overview of Opocrin S.p.A 41
Retina Associates of Cleveland, Inc. 42
Clinical Trial Overview of Retina Associates of Cleveland, Inc. 42
Icon Bioscience, Inc. 43
Clinical Trial Overview of Icon Bioscience, Inc. 43
The EMMES Corporation 44
Clinical Trial Overview of The EMMES Corporation 44
Alimera Sciences, Inc. 45
Clinical Trial Overview of Alimera Sciences, Inc. 45
ARCA biopharma, Inc. 46
Clinical Trial Overview of ARCA biopharma, Inc. 46
Fovea Pharmaceuticals SA 47
Clinical Trial Overview of Fovea Pharmaceuticals SA 47
Sanwa Kagaku Kenkyusho Co., Ltd. 48
Clinical Trial Overview of Sanwa Kagaku Kenkyusho Co., Ltd. 48
Bayer AG 49
Clinical Trial Overview of Bayer AG 49
Santen Pharmaceutical Co., Ltd. 50
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 50
Eyetech Pharmaceuticals, Inc. 51
Clinical Trial Overview of Eyetech Pharmaceuticals, Inc. 51
Valeant Pharmaceuticals International, Inc. 52
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 52
Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
Shaheed Beheshti Medical University 53
Clinical Trial Overview of Shaheed Beheshti Medical University 53
Kyoto University 54
Clinical Trial Overview of Kyoto University 54
Johns Hopkins University 55
Clinical Trial Overview of Johns Hopkins University 55
University of Toronto 56
Clinical Trial Overview of University of Toronto 56
Barnes Retina Institute 57
Clinical Trial Overview of Barnes Retina Institute 57
S:t Eriks Ogonsjukhus AB 58
Clinical Trial Overview of S:t Eriks Ogonsjukhus AB 58
Shiga University of Medical Science 59
Clinical Trial Overview of Shiga University of Medical Science 59
Duke University 60
Clinical Trial Overview of Duke University 60
Medical University of Vienna 61
Clinical Trial Overview of Medical University of Vienna 61
Ludwig-Maximilians-Universitat Munich 62
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 62
California Retina Consultants 63
Clinical Trial Overview of California Retina Consultants 63
Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P. 64
Manhattan Eye Ear & Throat Hospital 65
Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital 65
Yamagata University Hospital 66
Clinical Trial Overview of Yamagata University Hospital 66
Keio University Hospital 67
Clinical Trial Overview of Keio University Hospital 67
Stavanger University Hospital 68
Clinical Trial Overview of Stavanger University Hospital 68
The University of Chicago 69
Clinical Trial Overview of The University of Chicago 69
Shiraz University of Medical Sciences 70
Clinical Trial Overview of Shiraz University of Medical Sciences 70
Hospital Universitario Ramon y Cajal 71
Clinical Trial Overview of Hospital Universitario Ramon y Cajal 71
The Medical University of Graz 72
Clinical Trial Overview of The Medical University of Graz 72
Five Key Clinical Profiles 73
Appendix 214
Abbreviations 214
Definitions 214
Research Methodology 215
Secondary Research 216
About GlobalData 216
Contact Us 216
Disclaimer 216
Source 217


【レポート販売概要】

■ タイトル:Retinal Vein Occlusion:グローバル臨床試験レビューH1, 2013
■ 英文:Retinal Vein Occlusion Global Clinical Trials Review, H1, 2013
■ 発行日:2013年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160719
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。